278 related articles for article (PubMed ID: 17530471)
1. Lovastatin effects on bone mineral density in postmenopausal women with type 2 diabetes mellitus.
Safaei H; Janghorbani M; Aminorroaya A; Amini M
Acta Diabetol; 2007 Jun; 44(2):76-82. PubMed ID: 17530471
[TBL] [Abstract][Full Text] [Related]
2. Influence of number of pregnancies on bone mineral density in postmenopausal women of different age groups.
Gur A; Nas K; Cevik R; Sarac AJ; Ataoglu S; Karakoc M
J Bone Miner Metab; 2003; 21(4):234-41. PubMed ID: 12811629
[TBL] [Abstract][Full Text] [Related]
3. Prediction of bone mineral density of lumbar spine, hip, femoral neck and Ward's triangle by forearm bone mineral density.
Trivitayaratana W; Trivitayaratana P; Kongkiatikul S
J Med Assoc Thai; 2001 Mar; 84(3):390-6. PubMed ID: 11460941
[TBL] [Abstract][Full Text] [Related]
4. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study.
Yoshimura N; Kasamatsu T; Sakata K; Hashimoto T; Cooper C
J Bone Miner Metab; 2002; 20(5):303-10. PubMed ID: 12203037
[TBL] [Abstract][Full Text] [Related]
5. Total lymphocyte count and femoral bone mineral density in postmenopausal women.
Di Monaco M; Vallero F; Di Monaco R; Mautino F; Cavanna A
J Bone Miner Metab; 2004; 22(1):58-63. PubMed ID: 14691689
[TBL] [Abstract][Full Text] [Related]
6. [Change of bone mineral density in type 2 diabetes mellitus with nephropathy].
Lei MX; Liao L; Chen HL
Hunan Yi Ke Da Xue Xue Bao; 2000 Oct; 25(5):477-9. PubMed ID: 12212125
[TBL] [Abstract][Full Text] [Related]
7. Lumbar and femoral bone density in perimenopausal women with irregular cycles.
Perrone G; Galoppi P; Capri O; Anelli G; Borrello M; Zichella L
Int J Fertil Menopausal Stud; 1995; 40(3):120-5. PubMed ID: 7663538
[TBL] [Abstract][Full Text] [Related]
8. Benefit period using alendronate to increase bone mineral density in women with osteoporosis?
Ozdemir F; Rodoplu M
Chin Med J (Engl); 2005 Mar; 118(5):383-90. PubMed ID: 15780207
[TBL] [Abstract][Full Text] [Related]
9. Association between serum cholesterol and bone mineral density.
Makovey J; Chen JS; Hayward C; Williams FM; Sambrook PN
Bone; 2009 Feb; 44(2):208-13. PubMed ID: 18983946
[TBL] [Abstract][Full Text] [Related]
10. Relationship between carotid atherosclerosis and lumbar spine bone mineral density in postmenopausal women.
Sumino H; Ichikawa S; Kasama S; Takahashi T; Sakamoto H; Kumakura H; Takayama Y; Kanda T; Murakami M; Kurabayashi M
Hypertens Res; 2008 Jun; 31(6):1191-7. PubMed ID: 18716368
[TBL] [Abstract][Full Text] [Related]
11. Diabetes in postmenopause: different influence on bone mass according to age and disease duration.
Hadjidakis DI; Androulakis II; Mylonakis AM; Sfakianakis ME; Raptis AE; Papaefstathiou AG; Economopoulos TC; Raptis SA
Exp Clin Endocrinol Diabetes; 2009 May; 117(5):199-204. PubMed ID: 19085699
[TBL] [Abstract][Full Text] [Related]
12. Effects of dietary treatment on bone mineral density in adults with celiac disease: factors predicting response.
Ciacci C; Maurelli L; Klain M; Savino G; Salvatore M; Mazzacca G; Cirillo M
Am J Gastroenterol; 1997 Jun; 92(6):992-6. PubMed ID: 9177517
[TBL] [Abstract][Full Text] [Related]
13. Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women.
Tanriverdi HA; Barut A; Sarikaya S
Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):63-8. PubMed ID: 15866088
[TBL] [Abstract][Full Text] [Related]
14. HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients.
Chung YS; Lee MD; Lee SK; Kim HM; Fitzpatrick LA
J Clin Endocrinol Metab; 2000 Mar; 85(3):1137-42. PubMed ID: 10720052
[TBL] [Abstract][Full Text] [Related]
15. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of serum cholesterol on bone mineral density in women and men: the Framingham Osteoporosis Study.
Samelson EJ; Cupples LA; Hannan MT; Wilson PW; Williams SA; Vaccarino V; Zhang Y; Kiel DP
Bone; 2004 Mar; 34(3):557-61. PubMed ID: 15003803
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of eNOS gene polymorphisms in relation to BMD in postmenopausal women.
Firat SC; Cetin Z; Samanci N; Aydin F; Balci N; Gungor F; Firat MZ; Luleci G; Karauzum SB
Maturitas; 2009 Aug; 63(4):352-6. PubMed ID: 19520527
[TBL] [Abstract][Full Text] [Related]
18. Increase of bioavailable testosterone is associated with gain in bone mineral density after cure of primary hyperparathyroidism in postmenopausal women.
Almqvist EG; Becker C; Bondeson AG; Bondeson L; Svensson J
Clin Endocrinol (Oxf); 2006 Jan; 64(1):58-62. PubMed ID: 16402929
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes.
Anaforoglu I; Nar-Demirer A; Bascil-Tutuncu N; Ertorer ME
J Diabetes Complications; 2009; 23(1):12-7. PubMed ID: 18413190
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density in women with sarcoidosis.
Sipahi S; Tuzun S; Ozaras R; Calis HT; Ozaras N; Tuzun F; Karayel T
J Bone Miner Metab; 2004; 22(1):48-52. PubMed ID: 14691687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
